Since there isn’t a specific inhibitor of SUV39H1, we therefore used chaetocin to test the potential effect of this non-specific inhibitor of SUV39H1 in MA9 AML mouse models. This evidence concerns the gene SUV39H1 and acute myeloid leukemia.